Page last updated: 2024-09-04

ym 09151-2 and pindolol

ym 09151-2 has been researched along with pindolol in 1 studies

Compound Research Comparison

Studies
(ym 09151-2)
Trials
(ym 09151-2)
Recent Studies (post-2010)
(ym 09151-2)
Studies
(pindolol)
Trials
(pindolol)
Recent Studies (post-2010) (pindolol)
2496133,71866292

Protein Interaction Comparison

ProteinTaxonomyym 09151-2 (IC50)pindolol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.0005
Beta-1 adrenergic receptorHomo sapiens (human)0.0009
Beta-3 adrenergic receptorHomo sapiens (human)0.088
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.048
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)0.048

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatanaka, K; Hidaka, K; Matsumoto, M; Noda-Saita, K; Ohmori, J; Okada, M; Yamaguchi, T1

Other Studies

1 other study(ies) available for ym 09151-2 and pindolol

ArticleYear
Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
    Biochemical and biophysical research communications, 1999, Feb-16, Volume: 255, Issue:2

    Topics: Animals; Anisoles; Benzamides; Binding Sites; Cerebral Cortex; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Ketanserin; Ligands; Macaca fascicularis; Pindolol; Piperazines; Propylamines; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Serotonin; Sulfonamides; Tritium

1999